Live Quote · NASDAQDNLIHealthcare· Biotechnology

Denali Therapeutics Inc.

$18.45▲ 1.37%(+$0.25)
MKT CAP $2.96BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
43/100
▌ Weak
47
Valuation
40
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNLI research report →

Analyst Price Target
$33.86+83.5% vs. today

Range $26 – $41

Analyst RatingBuy
19 Buy0 Hold0 Sell

Price Chart

+7.52% · this period
$27.21$21.62$16.02Nov 20May 26Nov 20
52-Week Range26% of range
Low
$15.34
Current
$18.45
High
$27.30